Stay updated on Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial
Sign up to get notified when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.

Latest updates to the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedUpdated to v3.2.0 with an operational status notice; removed a specific disease resource (Cutaneous neuroendocrine carcinoma) and v3.1.0 reference.SummaryDifference2%
- Check20 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.0%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedUpdated version from v3.0.1 to v3.0.2 and removed the 'Back to Top' link. No changes to pricing, stock, or time slots.SummaryDifference0.1%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has been updated to include new facility information, specific publications related to clinical trials, and additional resources on skin and connective tissue diseases, while removing outdated location details and certain genetic resources.SummaryDifference7%
- Check56 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.